Comments
Loading...
Brainstorm Cell (BCLI) Forecast
NewsEarningsBrainstorm Cell (BCLI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBrainstorm Cell (NASDAQ:BCLI) Stock Quotes, Forecast and News Summary
Brainstorm Cell Stock (NASDAQ: BCLI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Brainstorm Cell (BCLI) stock?
You can purchase shares of Brainstorm Cell (NASDAQ:BCLI) through any online brokerage.
Who are Brainstorm Cell (BCLI) competitors?
Other companies in Brainstorm Cell’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Addex Therapeutics (NASDAQ:ADXN) and Evaxion Biotech (NASDAQ:EVAX).
What is the forecast, or price target, for Brainstorm Cell (BCLI) stock?
Brainstorm Cell has a consensus price target of $2.00.
What is the current price for Brainstorm Cell (BCLI)?
The stock price for Brainstorm Cell (NASDAQ: BCLI) is $1.28 last updated November 20, 2024 at 8:24 AM EST.
Does Brainstorm Cell (BCLI) pay a dividend?
There are no upcoming dividends for Brainstorm Cell.
When is Brainstorm Cell (NASDAQ:BCLI) reporting earnings?
Brainstorm Cell’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Brainstorm Cell (BCLI) going to split?
There is no upcoming split for Brainstorm Cell.
What sector and industry does Brainstorm Cell (BCLI) operate in?
Brainstorm Cell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.